Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Richard Sutton , Michele Brignole Added: 3 years ago
The implantable loop recorder (ILR) is a small device manufactured by Medtronic Inc., Minneapolis, MN, which is implanted subcutaneously close to the heart. It has the ability to record the electrical activity of the heart, store rhythm disturbances within set parameters and can be triggered by the patient to store events. The loop recorder is a device with a high diagnostic yield and offers… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Head of Cardio-oncology
DrFelipe Garza isHead of Cardio-oncology atOncare Treatment Center, San Pedro Garza Garcia, MX. Dr Garza is also president of the Mexican chapter of IC-OS. His research interests include cardiac imaging and surveillance in patients with positive HER-2 breast cancer. View more
Author(s): Simon G Pearse , Martin R Cowie , Rakesh Sharma , et al Added: 3 years ago
Despite advances in therapy, heart failure (HF) continues to be a leading cause of hospitalisation in those over 65.1 Around 2 % of people in Europe live with HF and as many as 10 % of those over 75 years are affected.2 Prognosis continues to be poor, with approximately half of patients dying within 5 years of first hospitalisation,3 a more severe prognosis than many malignancies.4 Sleep… View more
Author(s): Kirsten Tolstrup Added: 3 years ago
Ischaemic heart disease is the leading single cause of death in the US and elsewhere, and a major health problem worldwide.1 The direct cost of hospitalisations for ischaemic heart disease in the US alone is enormous and amounts to more than US$15 billion. Consequently, it is very important to facilitate more definitive ischaemia evaluation while avoiding unnecessary hospital admissions of non… View more
Author(s): Kirsten Tolstrup Added: 3 years ago
Ischaemic heart disease is the leading single cause of death in the US and elsewhere, and a major health problem worldwide.1 The direct cost of hospitalisations for ischaemic heart disease in the US alone is enormous and amounts to more than US$15 billion. Consequently, it is very important to facilitate more definitive ischaemia evaluation while avoiding unnecessary hospital admissions of non… View more
Author(s): Bjoern Stinn , Juergen Fornaro , Dennis Hibbeln , et al Added: 3 years ago
Computed tomography coronary angiography (CTCA) has entered the level of daily clinical practice in many institutions worldwide. All studies previously performed on the diagnostic accuracy of CTCA have shown a high negative predictive value, indicating a high ability of this method to exclude relevant coronary artery disease.1–3 However, CTCA is highly demanding not just of the technology, but… View more
Author(s): Stephen J Greene Added: 10 months ago
ESC-HFA 23 — Dr Stephen Greene (Duke University School of Medicine, US) outlines the findings from the QoL study of the TRANSFORM-HF Trial (NCT03296813). The TRANSFORM-HF trial is a randomized trial which compared torsemide to furosemide as a treatment for patients with heart failure. Around 2859 patients with heart failure were enrolled in the trial, whose clinical outcomes were measured across… View more
Author(s): William T Abraham , Hanad Bashir Added: 5 months ago
AHA 23 — Dr Hanad Bashir, CardioNerds ambassador, interviews Prof William T Abraham (The Ohio State University, US) on the findings of a clinical evaluation of the Cordio app in adult patients with acute decompensated heart failure.The Cordio "HearO" app (Cordio Medical) uses patient speech sampled via mobile phone to sense fluid accumulation related to chronic heart failure, and provides alerts… View more
Author(s): Didier Tchétché , Kendra J Grubb , Darren Mylotte , et al Added: 1 year ago
This symposium, part ofTranscatheter Interventions Online 2023, and chaired by Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR),presented and discussed the importance of first valve selection. The faculty considered why the choice of the first valve matters in younger and lower-risk patients with longer life expectancy. They also showed how the technical refinements in implementation are going… View more
Author(s): Keith AA Fox Added: 3 years ago
Cardiology was never forefront on my mind. I grew up in Central Africa in Zimbabwe where my father was a banker and I went to local schools. I always had an interest in the sciences so during a gap year between school and university I worked in the Queen Elizabeth Hospital in Malawi in the labs and trauma outpatient clinic. This fed my enthusiasm to pursue science and was really quite informative… View more